Paul Scherrer Institute
Overview
The Paul Scherrer Institute (PSI) is a multi-disciplinary research institute for natural and engineering sciences in Switzerland, which is part of the ETH Domain of the Swiss Confederation. While its primary focus is research, it supports the commercialization of its technologies through a Technology Transfer Office, which includes grants and fellowships to support spin-offs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Augetik | Sep 2024 | Grant | Co-investor |
| Focal Biosciences | Oct 2022 | Seed | Co-investor |
| GratXray AG | - | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Paul Scherrer Institute based?
Paul Scherrer Institute is headquartered in Villigen, Switzerland.
When was Paul Scherrer Institute founded?
Paul Scherrer Institute was founded in 1988.
How many portfolio companies does Paul Scherrer Institute have?
Paul Scherrer Institute has 4 portfolio companies in Caplight's dataset.
What are some companies in Paul Scherrer Institute's portfolio?
Portfolio companies visible on Caplight include Augetik, Focal Biosciences, GratXray AG.
What was Paul Scherrer Institute's most recent investment shown here?
Paul Scherrer Institute's most recent investment in this portfolio sample was in Augetik in 2024.
What sectors does Paul Scherrer Institute focus on?
Paul Scherrer Institute focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Paul Scherrer Institute focus on?
Stage focus information for Paul Scherrer Institute is not publicly available.